$87.62
1.301.51%
al cierre: -
$87.33
-0.29-0.33%
After hour: 6:56 PM EDT
Comments
Loading...
Merck & Co Actividad de operaciones con información privilegiada
MRKNYSE
Actividad de operaciones de insiders
Sigue la actividad de operaciones con información privilegiada más reciente de Merck & Co. Mantente informado sobre las compras, ventas e impacto en el mercado recientes de las acciones de Merck & Co.
¿Qué es la actividad interna?
La actividad de uso de información privilegiada involucra a personas con información privilegiada de la empresa, como ejecutivos, directores y empleados, que participan en transacciones con acciones de su propia empresa. Las transacciones de compra y venta de los iniciados proporcionan información valiosa sobre su confianza en el desempeño futuro de la empresa.
¿Qué están haciendo Merck & Co Inc los iniciados?
Los expertos no han informado de compras ni ventas en los últimos 30 días.
Compras y ventas recientes notables de información privilegiada
No ha habido ninguna compra o venta de información privilegiada en los últimos 90 días.
Estadísticas de propiedad de Merck & Co Inc
Acciones en circulación
2.498B
Acciones en manos de personas con información privilegiada
4.179M
Porcentaje de acciones en manos de personas con información privilegiada
0.17%
Acciones en manos de instituciones
1.299B
Porcentaje de acciones en manos de instituciones
52.0%
Apr 29, 2025 | SVP FIN. - GLOBAL CONTROLLER | 738.00 | $70.42 | -$62.32K | SELL-OPTIONS | 10.48% | 7.78K | Apr 25 | ||
Feb 20, 2025 | PRESIDENT, U.S. MARKET | -8.50K | $84.09 | -$714.74K | SELL | -21.68% | 30.71K | Feb 19 | ||
Feb 13, 2025 | EVP,CHIEF INFO&DIGITAL OFFICER | -6.00K | $85.34 | -$512.06K | SELL | -19.92% | 24.12K | Feb 13 | ||
Feb 07, 2025 | DIRECTOR | 2.83K | $88.25 | $250.00K | BUY | 2832.86% | 2.93K | Feb 06 | ||
Feb 07, 2025 | CHIEF COMM. & PUBLIC AFRS OFCR | -2.36K | $88.76 | -$209.55K | SELL | -24.99% | 7.08K | Feb 06 | ||
Feb 07, 2025 | DIRECTOR | 15.00K | $88.50 | $1.33M | BUY | 1500.00% | 16.00K | Feb 05 | ||
Feb 15, 2024 | EVP & CFO | 0.00 | $91.79 | -$2.58M | SELL-OPTIONS | 0.00% | 50.91K | Feb 14 | ||
Feb 15, 2024 | CHAIRMAN, CEO & PRESIDENT | 0.00 | $99.85 | -$12.14M | SELL-OPTIONS | 0.00% | 348.33K | Feb 13 - Feb 14 | ||
Feb 14, 2024 | PRESIDENT, HUMAN HEALTH INT?L | -1.00K | $124.89 | -$124.89K | SELL | -4.86% | 19.57K | Feb 13 | ||
Feb 12, 2024 | EXECUTIVE VP & PRESIDENT, MRL | 0.00 | $93.78 | -$932.53K | SELL-OPTIONS | 0.00% | 46.24K | Feb 09 | ||
Feb 08, 2024 | EVP,CHIEF INFO&DIGITAL OFFICER | -1.45K | $127.57 | -$185.11K | SELL | -6.82% | 19.81K | Feb 07 | ||
Feb 05, 2024 | PRESIDENT, U.S. MARKET | 1.98K | $102.99 | -$761.20K | SELL-OPTIONS | 9.26% | 23.33K | Feb 02 | ||
Feb 02, 2024 | EVP, CHIEF HR OFFICER | -17.70K | $100.15 | -$3.99M | SELL | -42.84% | 23.62K | Feb 02 | ||
Feb 02, 2024 | EVP, GENERAL COUNSEL | -30.08K | $107.03 | -$4.59M | SELL | -50.87% | 29.06K | Feb 02 | ||
Nov 13, 2023 | PRESIDENT, U.S. MARKET | -2.08K | $102.38 | -$213.06K | SELL | -10.27% | 18.19K | Nov 09 | ||
Nov 09, 2023 | EVP&PRES, MERCK ANIMAL HEALLTH | -43.82K | $105.03 | -$4.60M | SELL | -27.95% | 112.99K | Nov 08 | ||
Aug 15, 2023 | EVP, CHIEF HR OFFICER | -4.25K | $109.01 | -$463.29K | SELL | -15.63% | 22.94K | Aug 14 | ||
Aug 04, 2023 | EVP, CHIEF HR OFFICER | -4.50K | $105.49 | -$474.70K | SELL | -14.20% | 27.19K | Aug 03 | ||
Aug 03, 2023 | PRESIDENT, HUMAN HEALTH INT?L | -89.00 | $107.37 | -$9.56K | SELL | -100.00% | 0.00 | Aug 02 | ||
Jun 30, 2023 | PRESIDENT, HUMAN HEALTH INT?L | 374.00 | $106.53 | $40.67K | BUY | 1.85% | 20.60K | Dec 02 - Apr 26 | ||
May 05, 2023 | EVP, CHIEF HR OFFICER | -1.40K | $97.28 | -$2.43M | SELL | -4.23% | 31.69K | May 03 | ||
May 05, 2023 | EVP, GENERAL COUNSEL | -19.14K | $117.59 | -$2.25M | SELL | -35.27% | 35.13K | May 04 | ||
May 05, 2023 | SR. VP FINCE-GLOBAL CONTROLLER | 1.15K | $92.59 | -$744.70K | SELL-OPTIONS | 2.58% | 45.71K | May 03 - May 04 | ||
May 03, 2023 | EVP,CHIEF INFO&DIGITAL OFFICER | -1.09K | $89.01 | -$495.26K | SELL | -9.01% | 11.06K | May 01 - May 02 | ||
May 02, 2023 | EVP&PRES, MERCK ANIMAL HEALLTH | 0.00 | $87.20 | -$8.03M | SELL-OPTIONS | 0.00% | 155.70K | Apr 28 - May 01 | ||
Apr 28, 2023 | CHAIRMAN, CEO & PRESIDENT | 0.00 | $85.49 | -$8.44M | SELL-OPTIONS | 0.00% | 271.82K | Apr 28 | ||
Apr 14, 2023 | EXE V-P & PRES. MMD | 0.00 | $87.04 | -$7.51M | SELL-OPTIONS | 0.00% | 46.99K | Apr 13 | ||
Feb 16, 2023 | PRESIDENT, HUMAN HEALTH INT?L | -5.00K | $108.22 | -$541.10K | SELL | -19.78% | 20.28K | Feb 15 | ||
Feb 14, 2023 | EVP, CHIEF HR OFFICER | -1.81K | $109.10 | -$198.02K | SELL | -5.20% | 33.09K | Feb 13 | ||
Feb 10, 2023 | EVP, CHIEF HR OFFICER | -5.00K | $107.00 | -$535.01K | SELL | -12.53% | 34.90K | Feb 09 | ||
Feb 08, 2023 | EVP, CHIEF HR OFFICER | -4.44K | $104.25 | -$462.47K | SELL | -10.01% | 39.90K | Feb 06 | ||
Feb 06, 2023 | EVP, GENERAL COUNSEL | 0.00 | $79.61 | -$3.56M | SELL-OPTIONS | 0.00% | 53.92K | Feb 03 | ||
Jan 11, 2023 | EXE V-P & PRES. MMD | 0.00 | $82.68 | -$4.98M | SELL-OPTIONS | 0.00% | 75.11K | Jan 09 | ||
Nov 10, 2022 | EVP, CHIEF HR OFFICER | 0.00 | $101.18 | -$3.54M | SELL-OPTIONS | 0.00% | 32.14K | Nov 08 - Nov 10 | ||
Nov 10, 2022 | PRESIDENT, U.S. MARKET | -1.79K | $103.21 | -$185.26K | SELL | -9.69% | 16.73K | Nov 09 | ||
Nov 10, 2022 | CEO & PRESIDENT | 0.00 | $102.44 | -$17.17M | SELL-OPTIONS | 0.00% | 247.59K | Nov 09 | ||
Nov 08, 2022 | EXECUTIVE CHAIR | 0.00 | $99.55 | -$23.47M | SELL-OPTIONS | 0.00% | 705.13K | Nov 07 | ||
Nov 07, 2022 | PRESIDENT, U.S. MARKET | 7.18K | $99.47 | -$4.53M | SELL-OPTIONS | 63.31% | 18.53K | Nov 07 | ||
Nov 07, 2022 | EXECUTIVE CHAIR | 0.00 | $98.66 | -$46.37M | SELL-OPTIONS | 0.00% | 705.13K | Nov 03 - Nov 04 | ||
Nov 03, 2022 | EXECUTIVE CHAIR | -5.63K | $99.86 | -$59.91M | SELL | -0.79% | 705.13K | Nov 01 - Nov 02 | ||
Nov 01, 2022 | EXE V-P & PRES. MMD | 0.00 | $100.10 | -$10.04M | SELL-OPTIONS | 0.00% | 112.98K | Oct 28 | ||
Nov 01, 2022 | EVP&PRES, MERCK ANIMAL HEALLTH | 0.00 | $100.26 | -$16.50M | SELL-OPTIONS | 0.00% | 138.17K | Oct 28 | ||
Nov 01, 2022 | EXECUTIVE CHAIR | 0.00 | $100.44 | -$87.09M | SELL-OPTIONS | 0.00% | 710.76K | Oct 28 - Oct 31 | ||
Nov 01, 2022 | SR. VP FINCE-GLOBAL CONTROLLER | 0.00 | $100.34 | -$3.21M | SELL-OPTIONS | 0.00% | 41.10K | Oct 28 | ||
Nov 01, 2022 | EVP, CHIEF HR OFFICER | -8.00K | $99.63 | -$2.49M | SELL | -19.93% | 32.14K | Oct 28 | ||
Nov 01, 2022 | PRESIDENT, U.S. MARKET | -3.17K | $100.52 | -$317.41K | SELL | -21.84% | 11.34K | Oct 28 - Oct 30 | ||
Nov 01, 2022 | EVP, GENERAL COUNSEL | -16.61K | $99.38 | -$16.42M | SELL | -30.39% | 38.04K | Oct 28 | ||
Nov 10, 2021 | EXECUTIVE CHAIR | 0.00 | $82.26 | -$54.61M | SELL-OPTIONS | 0.00% | 591.14K | Nov 09 | ||
Nov 05, 2021 | EVP&PRES, MERCK ANIMAL HEALLTH | 0.00 | $90.40 | -$2.69M | SELL-OPTIONS | 0.00% | 118.09K | Nov 04 | ||
Nov 05, 2021 | EVP & CFO | 4.35K | $91.00 | -$1.67M | SELL-OPTIONS | 22.00% | 24.11K | Nov 04 | ||
Nov 04, 2021 | SR. VP FINCE-GLOBAL CONTROLLER | 0.00 | $88.45 | -$2.21M | SELL-OPTIONS | 0.00% | 35.80K | Nov 03 | ||
Nov 03, 2021 | EVP, CHIEF PATIENT OFFICER | 0.00 | $87.91 | -$8.46M | SELL-OPTIONS | 0.00% | 39.16K | Nov 01 | ||
Nov 02, 2021 | EVP & PRES ? HUMAN HEALTH | 1.20K | $87.96 | -$3.39M | SELL-OPTIONS | 1.22% | 98.88K | Oct 30 - Nov 01 | ||
Nov 02, 2021 | EXE V-P & PRES. MMD | 0.00 | $87.32 | -$2.15M | SELL-OPTIONS | 0.00% | 93.15K | Oct 29 | ||
Nov 02, 2021 | EVP&PRES, MERCK ANIMAL HEALLTH | 0.00 | $87.56 | -$11.86M | SELL-OPTIONS | 0.00% | 118.09K | Oct 29 | ||
May 11, 2021 | EVP & PRES ? HUMAN HEALTH | 0.00 | $78.32 | -$1.51M | SELL-OPTIONS | 0.00% | 96.10K | May 10 | ||
Nov 12, 2020 | — | -280.00K | $81.42 | -$22.80M | SELL | -40.24% | 415.75K | Nov 09 |
PREGUNTAS FRECUENTES
¿Es legal el uso de información privilegiada?
Las operaciones con información privilegiada son legales siempre que se notifiquen a la Comisión de Bolsa y Valores (SEC). El comercio ilegal de valores se produce cuando la persona con información privilegiada viola un deber fiduciario o no informa de sus operaciones.
¿Cuáles son algunos ejemplos de manipulación del mercado?
Las operaciones con información privilegiada, los esquemas de pump and dump, el front running y las operaciones de lavado son ejemplos de manipulación del mercado. Los inversores que siguen el movimiento de activos con información privilegiada deben pensar atentamente por qué estos operadores con información privilegiada están negociando sus acciones antes de seguir adelante.
Explora operaciones con información privilegiada sobre todos los valores.